Abstract
The adjunctive use of simvastatin for patients with ventilator-associated pneumonia (VAP) was associated with an increase in 28-day mortality, although not statistically significant.
Filter Results
Select search scope: search across all journals or within the current journal
Search this journal
Enter search terms…
/